Aequus Pharmaceuticals Inc.
TSXV: AQS.V0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Toronto Stock Exchange Ventures
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Douglas Glen Janzen
- Employees
- 12
- Headquarters
- Vancouver, Canada
- IPO year
- 2015
- Market cap
- CA$663.2K
- Website
- https://www.aequuspharma.ca
Loading AQS…
Loading profile data…Frequently asked questions about AQS
What does Aequus Pharmaceuticals Inc. (AQS.V) do?
Aequus Pharmaceuticals Inc., a specialty pharmaceutical company, develops and commercializes drugs in Canada. It focuses on various therapeutic areas, including neurology, ophthalmology, and transplantation. The company markets Vistitan, an ophthalmology product to reduce elevated intraocular pressure in patients with open angle glaucoma or ocul...
Where does AQS.V trade?
Aequus Pharmaceuticals Inc. (AQS.V) trades on the Toronto Stock Exchange Ventures.
What sector is AQS.V in?
Aequus Pharmaceuticals Inc. (AQS.V) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Aequus Pharmaceuticals Inc.?
Douglas Glen Janzen is the chief executive officer of Aequus Pharmaceuticals Inc. (AQS.V).
Where is Aequus Pharmaceuticals Inc. headquartered?
Aequus Pharmaceuticals Inc. is headquartered in Canada.
Does AQS.V pay a dividend?
Aequus Pharmaceuticals Inc. (AQS.V) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AQS.V go public?
Aequus Pharmaceuticals Inc. (AQS.V) completed its initial public offering in 2015.